Claire Wallace

Claire Wallace has over 30 years of experience in the life sciences, pharmaceutical and medical devices industries. She graduated as a microbiologist and began her career within the National Health Service (NHS) before joining Thermo Fisher Scientific in 1993. Since then, she has held leadership roles with increasing responsibility in quality, operations, marketing and sales. A passionate leader, Claire has built and led high-performing teams with a relentless focus on the customer and the patient.

In January of 2022, Claire assumed the role of Division President Microbiology within our Specialty Diagnostics Group. Claire has full P&L responsibility for 26 sites globally and over 2,800 employees. Prior to this role she held a number of senior level roles, across multiple disciplines, at Thermo Fisher spanning more than 25 years.

Claire obtained her BSc Hons in Applied Biology from Glasgow Caledonian University. She completed a post-graduate diploma in Quality Management at the University of West of Scotland and an international marketing diploma from INSEAD business school.

Claire lives in Glasgow with her husband, daughter and son.

COVID-19 has changed healthcare industry forever. The unparalleled demands placed on healthcare systems have disrupted old ways and exposed cracks but also opened our eyes to new possibilities. I was so inspired to see people pulling together, refusing to give up, and our industry showing a resilience to bring innovations to the market that positively impact patients’ lives. New vaccines. New diagnostic tools. New research efforts. A rethinking of healthcare provision and preparedness. Not to mention a whole new level of consumer awareness. Despite a largely remote workforce, the medtech industry rolled up its sleeve and used its scale to make a difference. I’m also deeply impressed by the superhuman response from nurses and doctors who deserve our utmost respect. Meanwhile, patients have become better informed and more empowered to take charge of their own health. Today, it seems, the “democratization” of healthcare is gaining momentum, fueled by new digital technologies and medical innovations. In a broader sense, healthcare access still faces many challenges: geographic issues, vaccine and testing availability, staffing shortages, costs and more. Nevertheless, my colleagues and I see strong potential to collaborate with our customers in making healthcare more accessible. Specifically, we see three key areas where we are enabling our customers to make the world healthier, cleaner, and safer: 1. BETTER POINT OF CARE DIAGNOSTICS Testing for many different common health conditions from allergies to disease can be made more accessible to patients, making it easier and faster to diagnose and treat common ailments. This is where companies like my own can collaborate to invest in R&D for faster, easier to access testing and information – much of which can be done from home or in local community settings (like a pharmacy, community care facility, nursing home, etc). Increasing testing accessibility can empower patients to take...